Cdc42 knockdown was even more effective at preventing tumour generation by HCC1954 (Basal-A with HER2 amplification) and HCC70 (Basal-A) cells, and no cells expressing shRNA for Cdc42 generated tumours even when 10,000 cells were transplanted. The gene discussed is ERBB2; the disease is neoplasm.